Giovanni Caforio

Giovanni Caforio currently works at Bristol-Myers Squibb Romania SRL, as Chairman & Chief Executive Officer, Novartis AG, as Chairman from 2025, Stryker Corp., as Independent Director from 2020, The Business Roundtable, as Member, European Federation of Pharmaceutical Industries & Assns, as Trustee, Hun School of Princeton, Inc., as Trustee, and CD&R LLP, as Operating Advisor from 2026.
Dr. Caforio also formerly worked at Pharmaceutical Research & Manufacturers of America, as Co-Chairman from 2019 to 2020, Bristol Myers Squibb Co., as Executive Chairman from 2023 to 2024, Capital Health System, Inc., as Director, National Pharmaceutical Council, as Director, TJ Holdings LLC, as Member, CEO Roundtable on Cancer, Inc., as Member, and Abbott Laboratórios Lda., as General Manager from 1988 to 2000.
Dr. Caforio received his doctorate degree in 1988 from Università degli Studi di Roma Tor Vergata.